Generic Available for Latisse
December 7, 2016 - Sandoz launched a generic for Latisse® (bimatoprost ophthalmic solution, 0.03% - Allergan). Bimatoprost is a prostaglandin that is indicated to treat hypotrichosis (thinning) of the upper eyelashes. When applied regularly to the base of the eyelashes on each upper eyelid, it darkens, lengthens and thickens lashes. Dosing is one drop to each upper eyelash every evening applied with disposable, single-use applicators that are dispensed with the solution. Available sizes are 3mL in a 4mL bottle (with 70 applicators) and 5mL in an 8mL bottle (with 140 applicators). Treated eyelids may darken, itch or swell and the colored parts of the eyes may darken, often irreversibly, as well. IMS Health estimated that U.S. sales for Latisse amounted to $75 million during the 12-month period that ended on Oct. 31, 2016.
Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Actual drug patent expiration dates and availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval. Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval. Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability.
*This is provided for information only. The reference to any medication above does not mean the medication is covered by your plan.